Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $109.5600 (3.13%) ($109.5600 - $110.0000) on Mon. Jan. 11, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.02% (three month average) | RSI | 63 | Latest Price | $109.5600(3.13%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1.7% a day on average for past five trading days. | Weekly Trend | LGND advances 1.2% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(56%) IWO(54%) IWM(51%) IWC(50%) XBI(50%) | Factors Impacting LGND price | LGND will decline at least -1.51% in a week (0% probabilities). VIXM(-23%) UUP(-17%) VXX(-15%) UNG(-3%) USO(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.51% (StdDev 3.02%) | Hourly BBV | 1.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $105.02(4.32%) | 10 Day Moving Average | $103.22(6.14%) | 20 Day Moving Average | $101.81(7.61%) | To recent high | 0% | To recent low | 36.4% | Market Cap | $1.761b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |